Description
Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury
COVID-19 UPDATE: We are open with limited hours and staff.
Artequick Tablets
Sh11,000.00
Quick Comparison
| Settings | Artequick Tablets remove | Aciclovir Skin Cream remove | AMINOPHYLINE TABLETS 100S remove | AMBROX DROPS 15ML remove | OFLOX OZ 200\500 MG remove | Ascard 75 Tablets remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh11,000.00 | Sh2,000.00 | Sh4,000.00 | Sh2,500.00 | Sh7,000.00 | Sh3,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description |
| Aminophylline tablets are a type of medicine known as a bronchodilator, which is used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect the lungs and airways. | Ambroxol drops are a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. | |||
| Content | Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury | Aciclovir belongs to a class of medication known as antivirals. It works by stopping the growth of the virus. This medication does not cure herpes, and it does not prevent passing the infection to someone else. It does not prevent a future occurrence. | The main uses of Aminophylline tablets include:
| The main uses of Ambroxol drops include:
| Used to treat:
| Ascard belongs to the category of Anti-platelet and Anti-coagulant drugs. It prevents blood clots and helps the blood in flowing smoothly. It is primarily used for the prevention of cardiovascular diseases and to relieve muscle aches, toothaches, and headaches. |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.